Advaxis Inc reports results for the quarter ended in April - Earnings Summary

Ayala Pharmaceuticals

14/06/2021 22:05

* Advaxis Inc  ADXS.OQ  reported a quarterly adjusted loss of 4
cents​​ per share for the quarter ended in April. The lone
analyst forecast for the quarter was for a loss of 5 cents per
share.
* Revenue rose 450% to $1.38 million from a year ago;  analysts
expected zero. 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Advaxis Inc shares had fallen by 30.0% this quarter and
gained 47.9% so far this year.
* The company reported a quarterly loss of $5.11 million.
* Wall Street's median 12-month price target for Advaxis Inc is
$2.25 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated June 14 at 09:05 p.m. GMT.
​All figures in US dollars